Skip to content
Researchers & MIT Community
Protect
Submit Disclosure
IPIA & Ownership
Understanding Intellectual Property
Tangible Property Licensing
Software & Open Source Protection
Learn
Technology Transfer Overview
Patenting & Commercializing Your Invention
Choosing Vendors & Merchandise
Learn More about IP
Connect
Connect with Your Licensing Officer
Office Hours
Events
Contact Us
Industry & Entrepreneurs
License
Browse Available Technologies
Technology Portfolios
Start the Licensing Process
License MIT’s Trademark
Understanding Expedited Licenses
Learn
Understanding the Licensing Process
Entrepreneurs & Startups
Meet MIT Researchers
Browse Startups
Learn More about IP
Connect
Connect with a Licensing Officer
Contact Us
Impact
About
Our Team
Join Our Mailing List
Annual Reports
Career Opportunities & Internships
FAQs
Submit Disclosure
Browse Technologies
Understand IP
Resources
News
Events
Our Team
Contact
Search
Content type
Search technologies only
Researchers & MIT Community
Protect
Submit Disclosure
IPIA & Ownership
Understanding Intellectual Property
Tangible Property Licensing
Software & Open Source Protection
Learn
Technology Transfer Overview
Patenting & Commercializing Your Invention
Choosing Vendors & Merchandise
Learn More about IP
Connect
Connect with Your Licensing Officer
Office Hours
Events
Contact Us
Industry & Entrepreneurs
License
Browse Available Technologies
Technology Portfolios
Start the Licensing Process
License MIT’s Trademark
Understanding Expedited Licenses
Learn
Understanding the Licensing Process
Entrepreneurs & Startups
Meet MIT Researchers
Browse Startups
Learn More about IP
Connect
Connect with a Licensing Officer
Contact Us
Impact
About
Our Team
Join Our Mailing List
Annual Reports
Career Opportunities & Internships
FAQs
Submit Disclosure
Browse Technologies
Understand IP
Resources
News
Events
Our Team
Contact
Search
Content type
Search technologies only
Ionizable Lipids for Messenger RNA
Delivery
Technology, Tangible Property /
Case number:
#24861
Jacob Witten / Idris Raji / Daniel Anderson
Technology Areas:
Chemicals & Materials / Drug Delivery / Drug Discovery and Research Tools / Therapeutics
Impact Areas:
Healthy Living
License
Anti-Zika Virus
Antibodies
Technology /
Case number:
#18525J
Kannan Tharakaraman / Eng Ooi / Kuan Chan / Satoru Watanabe / Subhash Vasudevan / Ram Sasisekharan
Technology Areas:
Drug Delivery / Therapeutics
Impact Areas:
Healthy Living
,
Uncharted Frontiers
License
Syntis Bio
2023
Technology Areas:
Biotechnology, Drug Discovery and Research Tools, Therapeutics
InnDura Therapeutics
2023
Technology Areas:
Biotechnology, Drug Delivery, Therapeutics
Cache DNA
2023
Technology Areas:
Biotechnology, Industrial Engineering & Automation, Therapeutics
Reconstituted Lipoprotein Particles to Rescue Lipid Defects in the Alzheimer's
Brain
Technology /
Case number:
#25445P
Li-Huei Tsai / Rebecca Pinals
Technology Areas:
Chemicals & Materials / Drug Discovery and Research Tools / Therapeutics
Impact Areas:
Healthy Living
License
Spatially Localized Gene Delivery of Adeno-Associated
Viruses
Technology /
Case number:
#25055
Polina Anikeeva / Keisuke Nagao
Technology Areas:
Chemicals & Materials / Drug Delivery / Therapeutics
Impact Areas:
Healthy Living
License
Augmentation of T and B Cell Activation with a Novel Cysteine Protease Linker
Sequence
Technology /
Case number:
#25338
Sean-Luc Shanahan / Tyler Jacks
Technology Areas:
Chemicals & Materials / Therapeutics
Impact Areas:
Healthy Living
License
Functionalization of MiniHA with Lauric
Acid
Technology /
Case number:
#20135
Bradley Olsen / Allie Obermeyer / Sieun Kim / Lavinia Popescu / Yun Jung Yang
Technology Areas:
Chemicals & Materials / Therapeutics
Impact Areas:
Healthy Living
License
Portal Insulin, LLC
2022
Technology Areas:
Drug Delivery, Therapeutics
Pagination
Page 1
Next page
››
Subscribe to Therapeutics